1	Suppression	suppression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	nuclear	nuclear	_	_	_	_	_	_	_
4	factor	factor	_	_	_	_	_	_	_
5	kappa	kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	CD18-mediated	cd18-mediated	_	_	_	_	_	_	_
9	leukocyte	leukocyte	_	_	_	_	_	_	_
10	adhesion	adhesion	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	corneal	corneal	_	_	_	_	_	_	_
14	endothelium	endothelium	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	dexamethasone	dexamethasone	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	PURPOSE	purpose	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	To	to	_	_	_	_	_	_	_
4	demonstrate	demonstrate	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	leukocyte	leukocyte	_	_	_	_	_	_	_
7	adhesion	adhesion	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	cultured	culture	_	_	_	_	_	_	_
10	corneal	corneal	_	_	_	_	_	_	_
11	endothelial	endothelial	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	mediated	mediate	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	CD18	cd18	_	_	_	_	_	_	_
18	antigen	antigen	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	determine	determine	_	_	_	_	_	_	_
23	whether	whether	_	_	_	_	_	_	_
24	dexamethasone	dexamethasone	_	_	_	_	_	_	_
25	directly	directly	_	_	_	_	_	_	_
26	suppresses	suppress	_	_	_	_	_	_	_
27	adhesion	adhesion	_	_	_	_	_	_	_
28	by	by	_	_	_	_	_	_	_
29	inhibiting	inhibit	_	_	_	_	_	_	_
30	activation	activation	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	nuclear	nuclear	_	_	_	_	_	_	_
33	factor	factor	_	_	_	_	_	_	_
34	kappa	kappa	_	_	_	_	_	_	_
35	B	B	_	_	_	_	_	_	_
36	(	(	_	_	_	_	_	_	_
37	NFkappaB	NFkappaB	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	METHODS	methods	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Cultured	culture	_	_	_	_	_	_	_
4	bovine	bovine	_	_	_	_	_	_	_
5	corneal	corneal	_	_	_	_	_	_	_
6	endothelium	endothelium	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	stimulated	stimulate	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	6	6	_	_	_	_	_	_	_
11	hours	hour	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	40	40	_	_	_	_	_	_	_
14	micron/ml	micron/ml	_	_	_	_	_	_	_
15	tumor	tumor	_	_	_	_	_	_	_
16	necrosis	necrosis	_	_	_	_	_	_	_
17	factor	factor	_	_	_	_	_	_	_
18	alpha	alpha	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	TNFalpha	TNFalpha	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Dexamethasone	Dexamethasone	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	added	add	_	_	_	_	_	_	_
4	1	1	_	_	_	_	_	_	_
5	hour	hour	_	_	_	_	_	_	_
6	before	before	_	_	_	_	_	_	_
7	TNFalpha	TNFalpha	_	_	_	_	_	_	_
8	stimulation	stimulation	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	dexamethasone	dexamethasone	_	_	_	_	_	_	_
12	group	group	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	After	after	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	neutrophils	neutrophil	_	_	_	_	_	_	_
5	separated	separate	_	_	_	_	_	_	_
6	from	from	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	healthy	healthy	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	volunteer	volunteer	_	_	_	_	_	_	_
11	were	be	_	_	_	_	_	_	_
12	added	add	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	or	or	_	_	_	_	_	_	_
15	without	without	_	_	_	_	_	_	_
16	anti-CD18	anti-cd18	_	_	_	_	_	_	_
17	antibody	antibody	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	culture	culture	_	_	_	_	_	_	_
3	plate	plate	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	settled	settle	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	15	15	_	_	_	_	_	_	_
8	minutes	minute	_	_	_	_	_	_	_
9	at	at	_	_	_	_	_	_	_
10	37	37	_	_	_	_	_	_	_
11	degrees	degree	_	_	_	_	_	_	_
12	C	C	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	then	then	_	_	_	_	_	_	_
16	neutrophils	neutrophil	_	_	_	_	_	_	_
17	were	be	_	_	_	_	_	_	_
18	activated	activate	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	N-formyl-methionyl-leucyl-phenylalanine	N-formyl-methionyl-leucyl-phenylalanine	_	_	_	_	_	_	_
21	for	for	_	_	_	_	_	_	_
22	5	5	_	_	_	_	_	_	_
23	minutes	minute	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	Nonadherent	nonadherent	_	_	_	_	_	_	_
2	neutrophils	neutrophil	_	_	_	_	_	_	_
3	were	be	_	_	_	_	_	_	_
4	removed	remove	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	sealing	seal	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	inverting	invert	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	culture	culture	_	_	_	_	_	_	_
11	well	well	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	intracellular	intracellular	_	_	_	_	_	_	_
3	localization	localization	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NFkappaB	NFkappaB	_	_	_	_	_	_	_
6	after	after	_	_	_	_	_	_	_
7	TNFalpha	TNFalpha	_	_	_	_	_	_	_
8	simulation	simulation	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	determined	determine	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	confocal	confocal	_	_	_	_	_	_	_
13	immunocytochemistry	immunocytochemistry	_	_	_	_	_	_	_
14	using	use	_	_	_	_	_	_	_
15	an	an	_	_	_	_	_	_	_
16	anti-p65	anti-p65	_	_	_	_	_	_	_
17	antibody	antibody	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	RESULTS	results	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Neutrophil	Neutrophil	_	_	_	_	_	_	_
4	adhesion	adhesion	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	cultured	culture	_	_	_	_	_	_	_
7	corneal	corneal	_	_	_	_	_	_	_
8	endothelial	endothelial	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	increased	increase	_	_	_	_	_	_	_
11	significantly	significantly	_	_	_	_	_	_	_
12	on	on	_	_	_	_	_	_	_
13	exposure	exposure	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	TNFalpha	TNFalpha	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	451.4+/-45.4	451.4+/-45.4	_	_	_	_	_	_	_
18	cells/mm2	cells/mm2	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	n	n	_	_	_	_	_	_	_
21	=	=	_	_	_	_	_	_	_
22	16	16	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	compared	compare	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	control	control	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	156.7+/-27.3	156.7+/-27.3	_	_	_	_	_	_	_
29	cells/mm2	cells/mm2	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	n	n	_	_	_	_	_	_	_
32	=	=	_	_	_	_	_	_	_
33	16	16	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	P	p	_	_	_	_	_	_	_
36	<	<	_	_	_	_	_	_	_
37	0.01	0.01	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	increased	increase	_	_	_	_	_	_	_
3	adhesion	adhesion	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	suppressed	suppress	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	addition	addition	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	anti-CD18	anti-cd18	_	_	_	_	_	_	_
11	antibody	antibody	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	157.6+/-25.1	157.6+/-25.1	_	_	_	_	_	_	_
14	cells/mm2	cells/mm2	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	n	n	_	_	_	_	_	_	_
17	=	=	_	_	_	_	_	_	_
18	8	8	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	P	p	_	_	_	_	_	_	_
21	<	<	_	_	_	_	_	_	_
22	0.01	0.01	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	by	by	_	_	_	_	_	_	_
26	pretreatment	pretreatment	_	_	_	_	_	_	_
27	with	with	_	_	_	_	_	_	_
28	10(-7)	10(-7)	_	_	_	_	_	_	_
29	M	M	_	_	_	_	_	_	_
30	dexamethasone	dexamethasone	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	207.9+/-31.5	207.9+/-31.5	_	_	_	_	_	_	_
33	cells/mm2	cells/mm2	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	n	n	_	_	_	_	_	_	_
36	=	=	_	_	_	_	_	_	_
37	10	10	_	_	_	_	_	_	_
38	,	,	_	_	_	_	_	_	_
39	P	p	_	_	_	_	_	_	_
40	<	<	_	_	_	_	_	_	_
41	0.01	0.01	_	_	_	_	_	_	_
42	)	)	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	Immunocytochemistry	Immunocytochemistry	_	_	_	_	_	_	_
2	60	60	_	_	_	_	_	_	_
3	minutes	minute	_	_	_	_	_	_	_
4	after	after	_	_	_	_	_	_	_
5	stimulation	stimulation	_	_	_	_	_	_	_
6	revealed	reveal	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	NFkappaB	NFkappaB	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	located	locate	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	cytoplasm	cytoplasm	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	unstimulated	unstimulated	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	;	;	_	_	_	_	_	_	_
18	however	however	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	addition	addition	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	TNFalpha	TNFalpha	_	_	_	_	_	_	_
24	caused	cause	_	_	_	_	_	_	_
25	NFkappaB	NFkappaB	_	_	_	_	_	_	_
26	to	to	_	_	_	_	_	_	_
27	translocate	translocate	_	_	_	_	_	_	_
28	into	into	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	nucleus	nucleus	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Pretreatment	Pretreatment	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	dexamethasone	dexamethasone	_	_	_	_	_	_	_
4	tapered	taper	_	_	_	_	_	_	_
5	NFkappaB	nfkappab	_	_	_	_	_	_	_
6	translocation	translocation	_	_	_	_	_	_	_
7	into	into	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	nucleus	nucleus	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	CONCLUSIONS	conclusions	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	Leukocyte	Leukocyte	_	_	_	_	_	_	_
4	adhesion	adhesion	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	corneal	corneal	_	_	_	_	_	_	_
8	endothelium	endothelium	_	_	_	_	_	_	_
9	was	be	_	_	_	_	_	_	_
10	shown	show	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	be	be	_	_	_	_	_	_	_
13	mediated	mediate	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	CD18	cd18	_	_	_	_	_	_	_
16	expressed	express	_	_	_	_	_	_	_
17	on	on	_	_	_	_	_	_	_
18	activated	activate	_	_	_	_	_	_	_
19	leukocytes	leukocyte	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Pretreatment	Pretreatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	endothelium	endothelium	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	dexamethasone	dexamethasone	_	_	_	_	_	_	_
7	inhibited	inhibit	_	_	_	_	_	_	_
8	leukocyte	leukocyte	_	_	_	_	_	_	_
9	adhesion	adhesion	_	_	_	_	_	_	_
10	;	;	_	_	_	_	_	_	_
11	this	this	_	_	_	_	_	_	_
12	may	may	_	_	_	_	_	_	_
13	be	be	_	_	_	_	_	_	_
14	due	due	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	part	part	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	suppression	suppression	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	NFkappaB	NFkappaB	_	_	_	_	_	_	_
22	entry	entry	_	_	_	_	_	_	_
23	into	into	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	nucleus	nucleus	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

